Learn / INBX
NASDAQ: INBX
Inhibrx Biosciences (INBX) stock, explained like you're 5
Inhibrx Biosciences trades on the Nasdaq under the ticker INBX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.4 billion dollars.
- Ticker
- INBX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 1.4 billion dollars
Is Inhibrx Biosciences a small, medium or large cap company?
No. Inhibrx Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Inhibrx Biosciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves INBX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Inhibrx Biosciences, Inc. (INBX) stock price, news, quote and history (Yahoo Finance UK)
- Inhibrx Announces Participation in Upcoming Scientific Conferences (PR Newswire)
- Two CEO linked trusts buy 10,040 Inhibrx Biosciences (INBX) shares; no trading plan is reported. (Stock Titan)
- Learn Why The Bull Case For Inhibrx Biosciences Stock Could Change Following Conference Data Presentations (Simply Wall Street)
- (INBX) Volatility Zones as Tactical Triggers (Stock Traders Daily)
Follow INBX in your daily brief
Each trading day at 5 PM ET we post what happened to Inhibrx Biosciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow INBX
Questions about Inhibrx Biosciences stock
What does Inhibrx Biosciences do?
Inhibrx Biosciences trades on the Nasdaq under the ticker INBX. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.4 billion dollars.
What is the ticker symbol for Inhibrx Biosciences?
Inhibrx Biosciences trades under the ticker INBX on the Nasdaq.
What is Inhibrx Biosciences's market cap?
Inhibrx Biosciences is a small cap stock with a market cap of about 1.4 billion dollars.
How does Inhibrx Biosciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves INBX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow INBX stock every day?
Add INBX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.